IDG Capital logo

IDG Capital

Asia, Beijing, China, Beijing

Description

IDG Capital, established in 1993, stands as a pioneering investment firm, notably being among the first foreign-backed venture capital entities to establish a presence in China. Headquartered in Beijing, the firm has evolved into a global powerhouse, renowned for its extensive investment activities across various stages, from early-stage startups to growth and pre-IPO companies. Its strategic focus spans a diverse array of sectors, including technology, media, and telecommunications (TMT), consumer goods and services, healthcare, advanced manufacturing, and new energy.

With a formidable track record, IDG Capital manages a significant portfolio, overseeing more than $30 billion in assets under management. This substantial capital base enables the firm to deploy considerable resources across its target markets. Over its decades of operation, IDG Capital has demonstrated a remarkable ability to identify and nurture promising ventures, having invested in over 1,000 companies globally. Its influence is particularly pronounced in the Chinese technology landscape, where it has backed numerous industry giants.

The firm's investment philosophy is characterized by a long-term perspective and a hands-on approach, providing not just capital but also strategic guidance and operational support to its portfolio companies. This comprehensive engagement has contributed to a strong record of successful exits, including over 200 initial public offerings (IPOs) and more than 100 merger and acquisition (M&A) deals. IDG Capital's typical first cheque size can range significantly, reflecting its multi-stage investment strategy, generally falling between $1 million for early-stage opportunities and up to $100 million for more mature, growth-stage companies seeking substantial capital injections. Their commitment to fostering innovation and market leadership has solidified their reputation as a pivotal player in the global venture capital ecosystem.

Investor Profile

IDG Capital has backed more than 352 startups, with 20 new investments in the last 12 months alone. The firm has led 93 rounds, about 26% of its total and boasts 164 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, India.
  • Strong thematic focus on Software, Internet, E-Commerce.
  • Led 8 rounds in the past year.
  • Typical check size: $1M – $100M.

Stage Focus

  • Series B (28%)
  • Series A (27%)
  • Series C (12%)
  • Seed (11%)
  • Series D (6%)
  • Angel (4%)
  • Series Unknown (4%)
  • Series E (2%)
  • Initial Coin Offering (1%)
  • Post Ipo Equity (1%)

Country Focus

  • China (58%)
  • United States (23%)
  • India (4%)
  • Singapore (4%)
  • Hong Kong (3%)
  • United Kingdom (1%)
  • South Korea (1%)
  • Ireland (1%)
  • France (1%)
  • Philippines (1%)

Industry Focus

  • Software
  • Internet
  • E-commerce
  • Manufacturing
  • Blockchain
  • Mobile
  • Artificial Intelligence (Ai)
  • Information Technology
  • Financial Services
  • Cryptocurrency
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does IDG Capital frequently co-invest with?

Sequoia Capital
North America, California, United States, Menlo Park
Co-Investments: 15
ZhenFund
Asia, Beijing, China, Beijing
Co-Investments: 19
GSR Ventures
North America, California, United States, Menlo Park
Co-Investments: 29
Matrix Partners China
Asia, Beijing, China, Beijing
Co-Investments: 16
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 14
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 30
Accel
North America, California, United States, Palo Alto
Co-Investments: 17
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 21
Lightspeed Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 13
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 31

Which angels does IDG Capital often collaborate with?

RL
North America, California, United States, San Francisco
Shared Deals: 2
Daniel Curran
North America, California, United States, Santa Monica
Shared Deals: 2
PG
Europe, Noord-Holland, The Netherlands, Amsterdam
Shared Deals: 1
Binny Bansal
Asia, Karnataka, India, Bengaluru
Shared Deals: 2
MT
North America, Tennessee, United States, Brentwood
Shared Deals: 1
MG
North America, California, United States, San Francisco
Shared Deals: 1
KH
Europe, Hamburg, Germany, Hamburg
Shared Deals: 1
ST
North America, California, United States, San Francisco
Shared Deals: 1
IH
Europe, England, United Kingdom, London
Shared Deals: 1
GC
Europe, Jersey
Shared Deals: 1

What are some of recent deals done by IDG Capital?

Sign

Singapore, Central Region, Singapore

Sign is a platform that helps users and AI agents receive crypto tokens more transparently.

BlockchainDecentralized Finance (DeFi)Web3
Series UnknownOct 21, 2025
Amount Raised: $25,500,000
Luxet

Suzhou, Jiangsu, China

Luxet is providing advanced nano-optical detection technology for industry, scientific research, and medical circles.

Advanced MaterialsSemiconductor
Series ASep 29, 2025
LeXiang Intelligence

Suzhou, Jiangsu, China

LeXiang Intelligence is a robotics company that specializes in the development of intelligent consumer-grade robots.

Intelligent SystemsManufacturingRobotics
AngelSep 28, 2025
Amount Raised: $28,035,746
Qualigen Therapeutics

Carlsbad, California, United States

Qualigen is a biotechnology company.

BiotechnologyHealth CarePharmaceutical
Post Ipo EquitySep 19, 2025
Amount Raised: $41,000,000

Rongguang Optics makes optical instruments, offers vacuum coating, industrial design, and plastic product manufacturing.

Series ASep 15, 2025
Amount Raised: $8,243,572
Hongxin Biology

Shenzhen, Guangdong, China

Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.

BiopharmaBiotechnologyMedical
SeedAug 29, 2025
Amount Raised: $14,026,032
Minova Pharma

Nanjing, Jiangsu, China

Minova Pharma focuses on the development of novel medications in the spiritual and medicinal beauty domains.

Series BAug 25, 2025
Amount Raised: $13,972,335
Transak

Brooklyn, New York, United States

Transak is a global web3 payment and onboarding infrastructure provider.

CryptocurrencyFinancial ServicesFinTechPaymentsWeb3
Series UnknownAug 12, 2025
Amount Raised: $16,000,000
Zhiran Medical

Beijing, Beijing, China

Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders.

Health CareMedical
Series AAug 4, 2025
Amount Raised: $41,787,968
Xunlu AI

Beijing, Beijing, China

Xunlu AI is an innovative startup that focuses on the development of AI-powered customer service technologies.

Artificial Intelligence (AI)Customer Service
Series AJul 29, 2025